The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet Healthcare (THC) closed the most recent trading day at $166.20, moving +1.83% from the previous trading session.
Despite being close to its peak, THC remains a compelling buy due to its solid fundamentals, appealing valuation, and upward trend in earnings estimates.
The Zacks Rank has consistently identified big winners, regardless of which pocket of the market they may reside.
Tenet Healthcare (THC) reachead $168.03 at the closing of the latest trading day, reflecting a +1.74% change compared to its last close.
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
The latest trading day saw Tenet Healthcare (THC) settling at $164.62, representing a +1.36% change from its previous close.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.